Compare LRE & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRE | SCNX |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | Japan | United States |
| Employees | N/A | 19 |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 19.0M |
| IPO Year | 2022 | N/A |
| Metric | LRE | SCNX |
|---|---|---|
| Price | $1.30 | $0.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 21.1K | ★ 2.2M |
| Earning Date | 07-30-2015 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $347.88 |
| Revenue Next Year | N/A | $744.44 |
| P/E Ratio | $3.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.37 |
| 52 Week High | $2.86 | $2.60 |
| Indicator | LRE | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 46.48 | 43.42 |
| Support Level | $1.20 | $0.39 |
| Resistance Level | $1.43 | $0.47 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 15.04 | 16.68 |
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.